Pacemakers, Defibrillators, and Cosmetic Surgery: Why Electrocautery Can Silence a Pacemaker or Trigger a Shock, What the Device Plan Should Look Like, Which Radiofrequency and Muscle-Stimulation Treatments Are Off Limits, and How Breast and Chest Surgery Works Around the Pocket

The patient is 66, had a pacemaker placed four years ago after a fainting spell traced to a slow heart rhythm, and feels better than they have in a decade. They want an upper and lower eyelid lift and a neck lift. The consultation went well until the intake form asked about implanted devices, and the coordinator, reading the answer, said the surgeon would "need a letter from cardiology." The patient asked what the letter should say. Nobody in the office knew.

That exchange is common, and it reflects a real gap. A cardiac device is not a reason to avoid cosmetic surgery. It is a reason to plan one specific part of the operation carefully: the electrical energy used to cut tissue and stop bleeding, which a pacemaker or defibrillator can misread as a heartbeat or as a dangerous rhythm. The planning involves the surgeon, the anesthesia team, and the clinic or physician who manages the device, and the "letter from cardiology" is only useful if it answers a handful of precise questions.

This piece explains those questions. It covers the major device types, including traditional pacemakers, implantable cardioverter-defibrillators (usually shortened to ICDs), cardiac resynchronization devices, and the smaller leadless and subcutaneous designs, and it extends the earlier pieces on anesthesia and the operative plan and pre-operative testing, neither of which had room for device management.

What actually happens when electrosurgery meets a cardiac device

The short answer: the electrical current from monopolar electrocautery, the standard surgical tool for cutting and sealing vessels, creates electromagnetic interference that a pacemaker may misread as the heart's own activity and stop pacing, or that a defibrillator may misread as a life-threatening rhythm and deliver an unnecessary shock, and the risk depends on the type of device, how dependent the patient is on it, and how close the surgery is to the device and its leads.

A pacemaker does two things continuously. It listens to the heart through wires called leads, and when it hears nothing for longer than its programmed interval, it sends a small pulse to make the heart beat. An ICD listens for dangerously fast rhythms and, when it detects one, either paces rapidly to interrupt it or delivers a shock. Both decisions depend on correctly interpreting electrical signals measured in thousandths of a volt.

Monopolar electrocautery, often called the Bovie after William T. Bovie, the physicist who developed the early electrosurgical unit in the 1920s, sends high-frequency current from a pen-shaped instrument through the patient's body to a grounding pad stuck on the skin. That current is enormous compared with the heart's own signals. If its path runs near the device or the leads, the device can pick it up as noise. The consequences fall into a few categories:

• Pacing inhibition. The pacemaker interprets the noise as heartbeats and withholds pacing. For a patient whose heart beats adequately on its own, this barely matters. For a patient who is pacemaker-dependent, meaning their own rhythm is too slow or absent without the device, a few seconds of inhibition can mean a dangerously slow heart rate or a pause.
• Inappropriate shocks. An ICD can interpret the noise as ventricular fibrillation and deliver a shock while the patient is on the table. That is uncomfortable under sedation, potentially dangerous, and a recognized cause of tissue burns and operative chaos.
• Mode changes and resets. Strong interference can occasionally push a device into a backup or reset mode with different settings than those the cardiologist chose.
• Heating at the lead tip. Rarely, current traveling along a lead can heat the point where it contacts the heart muscle, which can change how well the lead works afterward.

The guidance most anesthesia departments follow comes from a 2011 expert consensus statement from the Heart Rhythm Society and the American Society of Anesthesiologists, along with a practice advisory from the American Society of Anesthesiologists that has since been updated. One of the clearest practical principles in both is location: monopolar cautery used below the umbilicus is much less likely to interfere with a device in the upper chest than cautery used above it. That has a direct implication for cosmetic surgery, because a large share of aesthetic operations are on the face, neck, and chest, all of which sit close to the device.

Several techniques lower the risk regardless of location:

• Bipolar cautery, in which current passes only between the two tips of a forceps, keeps the electrical path tiny and far from the heart. Much of the fine work in eyelid and facial surgery can be done with it.
• Ultrasonic and other non-electrical instruments cut and seal tissue using vibration or other energy rather than current through the body.
• Grounding pad placement so that the path from the cautery tip to the pad does not cross the chest. For a facelift, a pad on the shoulder opposite the device, rather than on the thigh, can shorten and redirect the current path.
• Short, intermittent bursts rather than long continuous activation, which gives a pacemaker time to sense real beats between bursts.

The pre-operative device plan, and what the cardiology letter should say

The short answer: before any operation using monopolar cautery near the device, the team needs to know the device type and manufacturer, the reason it was placed, whether the patient is pacemaker-dependent, when it was last checked, and how it will be managed during surgery, whether by reprogramming or by placing a magnet over it, and the plan has to include a way to restore normal function and confirm it before the patient leaves.

A generic note saying a patient is "cleared for surgery" does not answer any of those questions. A useful device plan, usually written by the cardiologist or the device clinic that follows the patient, covers:

• Device identification. Every patient receives a wallet card listing the manufacturer and model. Bring it. The manufacturer matters because devices respond differently to magnets and reprogramming, and each major manufacturer runs a technical support line that operating rooms can call.
• Indication and dependency. Why the device was placed and whether the patient can maintain a safe heart rhythm without it. This single fact shapes most of the plan.
• Last interrogation. An interrogation is a check using a wireless programmer that reads battery life, lead function, settings, and recorded rhythm events. The consensus guidance suggests a check within roughly the past twelve months for pacemakers and the past six months for ICDs and resynchronization devices before elective surgery. A device near the end of its battery life may need replacement before any elective operation.
• The intraoperative strategy. For a pacemaker-dependent patient having surgery above the umbilicus with monopolar cautery, the device is often reprogrammed to an asynchronous mode, in which it paces at a fixed rate regardless of what it senses, so interference cannot inhibit it. For an ICD, the tachycardia therapies are suspended so interference cannot trigger a shock.
• Magnet versus reprogramming. A clinical magnet placed over most pacemakers temporarily switches them to asynchronous pacing; over most ICDs, it suspends shock therapy without changing pacing behavior. Magnets are quick and the effect stops when the magnet is removed, but responses vary by manufacturer and programming, and some devices are programmed to ignore magnets entirely. A magnet over an ICD in a pacemaker-dependent patient protects against shocks but not against inhibition. That is why the plan should come from someone who knows the specific device rather than from a general rule.
• Backup protection. When an ICD's therapies are suspended, the patient has lost their own protection against a fatal rhythm. External defibrillator pads are placed on the skin and connected to a defibrillator in the room for the duration, and continuous heart monitoring stays in place until the device is reactivated.
• Restoration. The plan should name who will restore the original settings, when, and where. The consensus is that a patient whose ICD therapies have been turned off should not leave a monitored setting until they are turned back on.

"

A cardiac device is rarely the reason a cosmetic operation should not happen. It is the reason someone in the room has to know exactly what the device will do when the cautery is pressed, and exactly how to undo whatever was done to it.

"

The other pieces of the medical plan follow from why the patient has the device. Many people with pacemakers or ICDs also take blood thinners for atrial fibrillation, mechanical heart valves, or prior clots, which brings in everything covered in the piece on blood thinners before cosmetic surgery. Many take beta blockers or other rhythm medications that should not be stopped, discussed in the piece on blood pressure and cosmetic surgery. ICD patients often have reduced heart pumping function, which is a much larger factor in anesthesia risk than the device itself. Patients with heart failure or a weak heart muscle are not good candidates for long combined procedures, and that is where the device conversation often turns into a conversation about scope.

The facility matters too. A procedure that requires reprogramming a device, placing defibrillator pads, and monitoring until restoration needs a setting equipped and staffed for it. Many office suites are set up for healthy patients, as described in the piece on outpatient facility accreditation. An ambulatory surgery center with an anesthesiologist and access to a device programmer, or a hospital, is often the more appropriate choice. Patients who have had a device placed recently should also wait: newly implanted leads can dislodge in the first weeks while scar tissue anchors them, and most cardiologists prefer that elective surgery wait until the device team is satisfied the system is stable.

Which energy-based cosmetic treatments are and are not compatible

The short answer: the treatments most likely to be off limits are those that drive electrical or electromagnetic energy into the body, including radiofrequency microneedling, monopolar radiofrequency skin tightening, high-intensity electromagnetic muscle stimulation, radiofrequency-assisted liposuction, electrolysis, and home microcurrent devices, while lasers, intense pulsed light, injectables, and chemical peels generally do not interact with a cardiac device.

The aesthetic treatment room is full of devices that put energy into tissue, and their manufacturers' labeling is the first source to check. In general terms:

• Radiofrequency microneedling and monopolar radiofrequency. Systems that deliver radiofrequency current through needles or a treatment tip, discussed in the pieces on energy-based skin tightening and on enlarged pores, commonly list pacemakers and implanted defibrillators as contraindications in their labeling. Some bipolar designs are considered lower risk, but a patient should not assume that, and many practices simply decline to treat.
• High-intensity electromagnetic muscle stimulation. The body-contouring and facial muscle-stimulation devices covered in the piece on EMFACE and facial muscle stimulation list pacemakers, defibrillators, and other implanted electronic devices as contraindications. A strong pulsing magnetic field near an electronic implant is exactly what device manufacturers warn against.
• Radiofrequency-assisted liposuction and helium plasma devices. Technologies that combine liposuction with internal radiofrequency or plasma energy, compared in the piece on skin tightening with liposuction, are electrosurgical in nature, and their use near the chest or in a device patient requires the same planning as cautery or may not be recommended at all.
• Electrolysis for hair removal. The galvanic and thermolysis methods pass current through the skin, and cardiac devices have traditionally been a reason for caution. The piece on laser hair removal is relevant here, because lasers do not carry the same concern.
• Home microcurrent devices. The facial toning gadgets sold for home use typically warn against use by people with pacemakers or other implanted electronic devices. The warning is in the instructions; patients rarely read it.
• Ultrasound-based skin tightening. Microfocused ultrasound uses sound energy rather than current, but labeling for some systems still advises caution with active implants, particularly in or near the treatment area. Treating the face of a patient with a device in the chest is a different question from treating the chest itself.

By contrast, lasers and intense pulsed light, including the treatments in the pieces on laser resurfacing and vascular lasers for redness, deliver light, not current, and do not interfere with device function. Fillers, neurotoxins, chemical peels, and cryolipolysis have no electrical interaction either. The usual caveat applies: a patient on blood thinners for the same heart condition will bruise more after injections, and a patient with heart failure may not tolerate long sessions lying flat.

Small office procedures deserve a mention because they are where device precautions are most often forgotten. The removal of skin tags, spots, and small growths covered in the piece on seborrheic keratoses and skin tags is frequently done with a small electrosurgical unit in a dermatology or aesthetic office, sometimes on the neck or upper chest directly over the device. Short bursts of low-power hyfrecation are generally considered low risk, but "generally" is not the same as "for this patient," and a pacemaker-dependent patient or an ICD patient should mention the device before any treatment that uses a buzzing or sparking tip.

Breast, chest, and neck surgery near the device pocket

The short answer: surgery close to the device, including breast augmentation, breast lift or reduction, chest liposuction, gynecomastia excision, and neck procedures on the device side, is usually possible but requires knowing exactly where the generator and leads sit, avoiding the device pocket, and treating any infection that approaches it as serious, because an infected cardiac device often has to be removed entirely.

Most transvenous pacemakers and ICDs sit in a pocket under the skin or muscle of the upper chest, just below the collarbone, usually on the left. The leads run from the generator into a vein beneath the collarbone and down into the heart. In some younger women, cardiologists place the generator beneath the breast through an incision in the fold, specifically for cosmetic reasons, which puts the device in the same territory a breast surgeon works in. The subcutaneous ICD, a newer design, sits along the left side of the chest wall near the armpit, with a lead tunneled along the breastbone, outside the heart entirely. Leadless pacemakers are small capsules implanted inside the heart with no chest pocket at all.

Each layout changes the surgical map:

• Breast augmentation. The upper pole of an implant pocket can approach a conventional generator in a thin patient, and dissecting a pocket beneath the chest muscle on the device side brings instruments closer to the leads. Incision choice matters: an approach through the armpit, one of the options in the piece on breast augmentation incisions, runs directly through the territory of a subcutaneous ICD and is usually avoided on that side. Imaging or the operative note from the device implant should tell the surgeon exactly where everything is.
• Breast lift and reduction. These operations are mostly lower on the chest, but they still involve extensive cautery on the chest wall, which is above the umbilicus by definition. The device plan applies in full.
• Chest liposuction and gynecomastia surgery. The male chest procedures described in the piece on gynecomastia surgery can bring a cannula or excision close to a generator in a lean patient. The pocket should be marked on the skin before surgery and avoided.
• Neck lift and facelift. These are not near the generator, but they are close enough to the chest that most guidelines treat them as above-the-umbilicus cases. Bipolar cautery handles much of the delicate work in a neck lift, with monopolar used sparingly under the device plan.

Infection is the most serious concern near the pocket. Device infections are difficult to treat because bacteria form a film on the hardware, and the standard approach to a confirmed infection of the generator or leads is removal of the entire system, including the leads from inside the heart, followed by a new implant later. That is a major operation with real risks. Anything that could seed the pocket, such as an infected seroma, a wound breakdown, or a hematoma tracking toward the device, deserves early, aggressive attention. Patients should know the warning signs at the pocket itself: new redness, warmth, swelling, drainage, or the skin over the generator thinning or darkening.

Bleeding interacts with infection. Patients on anticoagulants who develop a collection of blood near the surgical site face a higher risk of complications, and the pocket itself can fill with blood if it is disturbed. The steps described in the piece on hematoma after a facelift, including blood pressure control and early drainage, apply to any operation in these patients.

Tumescent fluid, the dilute lidocaine and epinephrine solution used in liposuction, is another quiet consideration. Epinephrine raises the heart rate and can provoke irregular rhythms in a heart that is already prone to them, and lidocaine interacts with some rhythm medications. The dose limits discussed in the piece on lidocaine toxicity in tumescent liposuction are worth reviewing with the anesthesia team for any patient with a rhythm disorder.

After surgery: device checks, warning signs, and recovery

The short answer: if the device was reprogrammed, had a magnet applied, or was exposed to significant cautery near the chest, it should be checked and restored before the patient leaves a monitored setting, and afterward the patient should report dizziness, fainting, a racing or very slow pulse, a shock, or any change at the device pocket right away.

The consensus guidance is direct about this. A device that was reprogrammed for surgery must be returned to its original settings, and an ICD whose shock therapy was suspended must be reactivated, before the patient is released from continuous monitoring. Even when no reprogramming occurred, many device clinics prefer a check after any operation in which monopolar cautery was used near the chest, to confirm that the settings, the lead function, and the battery are unchanged. Many modern devices also transmit data remotely from a bedside monitor, which lets the device clinic review recorded events without an extra visit. The patient should know which of these will happen and who will call them with the result.

At home, the warning signs are the same as those the device team has always given, now with surgery in the mix:

• Dizziness, lightheadedness, or fainting. Could reflect a device problem, a rhythm problem, blood loss, or medications. All warrant a call, and fainting warrants emergency care.
• A shock from an ICD. A single shock with a patient who feels well afterward usually calls for contacting the device clinic the same day. More than one shock, or a shock with chest pain or fainting, is an emergency.
• A very fast or very slow pulse, especially compared with the pacemaker's programmed lower rate, which the device clinic can provide.
• Hiccups that do not stop or a twitching in the chest or abdomen, which can indicate a lead that has shifted and is stimulating the diaphragm.
• Changes at the pocket: redness, swelling, warmth, drainage, or pain over the generator.

Recovery itself follows the same principles as for anyone else, with a few adjustments. Compression garments and chest binders should not press directly on a generator, and a well-padded or adjusted garment is easy to arrange if the issue is raised in advance. Arm restrictions after breast surgery, described in the piece on raising the arms after breast surgery, resemble the restrictions patients followed after their device was implanted, and the two rarely conflict once the leads are mature. Walking early to prevent blood clots matters as much for device patients as for anyone, and arguably more for those with heart failure, who already carry a higher baseline risk.

Imaging is a long-term consideration. Many current devices are labeled MR-conditional, meaning MRI scans are possible under specific conditions, but older systems may not be. Breast implants do not change that calculation, though the piece on breast imaging after implants explains how they affect mammography and MRI interpretation. Patients should keep the operative note from their cosmetic surgery alongside the device card, for the reasons explained in the piece on keeping medical records after cosmetic surgery. The next cardiologist, or the next surgeon replacing a generator whose battery has run down, will want to know what was done in that part of the chest.

Other implanted electronic devices raise similar questions. Spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, cochlear implants, and implanted drug pumps each have their own manufacturer guidance on cautery and energy-based treatments, and the same logic applies: identify the device, ask the team that manages it, and plan before the operation rather than on the morning of it. The earlier piece on multiple sclerosis and cosmetic surgery covers one example, the implanted baclofen pump, in more detail.

The honest summary

A pacemaker or defibrillator does not rule out cosmetic surgery, and most patients with stable devices and stable hearts can have facial, breast, and body procedures safely. What they need is a device plan, not a vague clearance. The core risk is electrical interference from monopolar cautery, which can stop a pacemaker from pacing in a patient who depends on it or trigger an unnecessary shock from an ICD. That risk is greatest for operations above the umbilicus, which describes most of cosmetic surgery, and it is managed through device identification, a recent interrogation, a specific plan for reprogramming or magnet use, bipolar or non-electrical instruments where possible, careful grounding pad placement, external defibrillation backup, and restoration of the device before the patient leaves a monitored setting.

Outside the operating room, the aesthetic treatments to question are those that push current or strong electromagnetic fields into the body: radiofrequency microneedling, monopolar radiofrequency, electromagnetic muscle stimulation, radiofrequency-assisted liposuction, electrolysis, and home microcurrent devices. Lasers, light, injectables, and peels are compatible. Small office electrosurgery on the neck or chest is low risk for most patients but should never happen without the device being mentioned first.

Surgery near the device, especially on the breast and chest, is possible with careful mapping of the generator and leads, avoidance of the pocket, and a low threshold for treating anything that looks like infection, because an infected device usually has to come out. The underlying heart condition, and the blood thinners and rhythm medications that often come with it, frequently matter more than the device itself.

The patient at the top of this piece had their eyelid and neck surgery at an ambulatory surgery center. The device clinic sent a one-page plan, the anesthesiologist reprogrammed the pacemaker that morning with the manufacturer's representative present, the surgeon used bipolar cautery for most of the work, and the pacemaker was checked and restored before discharge. Nothing about it was dramatic. That is what a device plan is for.